Marsh & McLennan CEO Exercises Options and Sells $3.14M Under 10b5-1 Plan
MARSH & MCLENNAN COMPANIES, INC.
Subscribe to track MRSH
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Marsh & McLennan Companies, Inc. ($MRSH) Form 4 Filing Summary • Insider: John Q. Doyle (President & CEO) • Transaction Date: September 2, 2026 • Action: Option Exercise & Sale (Rule 10b5-1) • Shares Sold: 16,656 shares @ $188.51 ($3,139,822.56 total value) • Shares Retained: 116,811.02 shares directly held
Comprehensive Analysis
Insider Transaction Overview
On September 2, 2026, John Q. Doyle, President and CEO of Marsh & McLennan Companies, Inc. ($MRSH), executed a pre-planned stock option exercise and subsequent open-market sale under a Rule 10b5-1 trading plan.
Transaction Details
-
Derivative Exercise (Stock Options):
- Shares Exercised: 16,656
- Exercise Price: $73.195 per share
- Total Exercise Cost: $1,219,135.92
- Options Remaining: 16,656 options
-
Non-Derivative Disposition (Common Stock):
- Shares Sold: 16,656 shares
- Execution Price: $188.51 per share
- Gross Proceeds: $3,139,822.56
- Net Profit (Pre-tax): ~$1,920,686.64
- Post-Transaction Direct Holdings: 116,811.0205 shares
Strategic Context & Market Impact
- Rule 10b5-1 Plan: The transaction was conducted under a pre-established 10b5-1 trading plan, indicating this was a scheduled liquidity event rather than a discretionary market timing move.
- Holding Impact: Following the transaction, Doyle maintains substantial direct ownership in the company (116,811+ shares), preserving meaningful alignment with shareholders.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.